Class IIITerminatedD-0078-2018
Drug recall · November 22, 2017
Lumigan recall
Why: Failed Impurities/Degradation Specifications.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Lumigan (bimatoprost ophthalmic solution) 0.01%, 2.5 mL bottle, Rx only, Allergan, Irvine, CA 92612. NDC# 0023-3205-03
- Lots / codes
Lot #: 92575 Exp. JUN-2018
- Quantity
- 153,616 bottles
- Company
- Allergan Sales, LLC, Waco, TX
- Distribution
- Nationwide and Barbados, Curacao, Dominican Republic, Guyana, Jamaica, and Trinidad and Tobago.
- Initiated
- October 19, 2017 · Voluntary: Firm initiated
- Classified
- November 13, 2017
- Reported
- November 22, 2017
- Ended
- October 30, 2019
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Lumigan
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.